NCT01846975View on ClinicalTrials.gov

Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a Holiday

PHASE4CompletedINTERVENTIONAL

Enrollment

49

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

December 31, 2014

Study Completion Date

January 31, 2015

Conditions

Rheumatoid Arthritis

Interventions

DRUG

IV Abatacept

Transition from weekly SC- to a single IV-Abatacept but also the return to weekly SC treatments after a 4 week break.

Trial Locations (1)

9007

Kantonsspital St. Gallen, Sankt Gallen

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Rüdiger B. Müller

OTHER

NCT01846975 - Introducing a Single IV Abatacept Treatment in RA Patients Currently Receiving Weekly SC Abatacept to Simulate a Holiday | Biotech Hunter | Biotech Hunter